ArticleEBioMedicine2020

Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections.

Laura A Novotny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.